Peripheral blood stem cell apheresis in normal donors: Feasibility and yield of second collections

被引:29
作者
Anderlini, P [1 ]
Lauppe, J [1 ]
Przepiorka, D [1 ]
Seong, D [1 ]
Champlin, R [1 ]
Korbling, M [1 ]
机构
[1] UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT HEMATOL,SECT BLOOD & MARROW TRANSPLANTAT,HOUSTON,TX 77030
关键词
peripheral blood stem cell(s); filgrastim; normal donors; allogeneic blood stem cell transplantation;
D O I
10.1046/j.1365-2141.1997.d01-2013.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report 13 normal peripheral blood stem cell (PBSC) donors who had a second PBSC collection for allogeneic transplantation performed after the first, The median interval between the first and second collection was 5 months. Mobilization was achieved with filgrastim (12 mu g/kg/d). No significant difference was found in the median pre-apheresis leucocyte count (x10(9)/l) between the two donations (40.2 v 38.5; P = 0.91). The median apheresis yield (x10(6) CD34(+) cells/litre blood processed, first apheresis) was also similar (28 v 27.3; P = 0.91). Filgrastim-related adverse events were comparable. These data suggest that second PBSC collections are feasible, similarly tolerated and provide comparable apheresis yields.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 9 条
[1]   Duration of filgrastim mobilization and apheresis yield of CD34(+) progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation [J].
Anderlini, P ;
Przepiorka, D ;
Huh, Y ;
Lauppe, J ;
Miller, P ;
Sundberg, J ;
Seong, D ;
Champlin, R ;
Korbling, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) :940-942
[2]   Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures [J].
Anderlini, P ;
Przepiorka, D ;
Seong, D ;
Miller, P ;
Sundberg, J ;
Lichtiger, B ;
Norfleet, F ;
Chan, KW ;
Champlin, R ;
Korbling, M .
TRANSFUSION, 1996, 36 (07) :590-595
[3]  
ANDERLINI P, 1996, IN PRESS TRANSFUSION
[4]  
BORTIN MM, 1993, BONE MARROW TRANSPL, V12, P97
[5]  
DAVIES SM, 1994, BONE MARROW TRANSPL, V13, P51
[6]   G-CSF-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION - SAFETY, KINETICS OF MOBILIZATION, AND COMPOSITION OF THE GRAFT [J].
DREGER, P ;
HAFERLACH, T ;
ECKSTEIN, V ;
JACOBS, S ;
SUTTORP, M ;
LOFFLER, H ;
MULLERRUCHHOLTZ, W ;
SCHMITZ, N .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (03) :609-613
[7]   PERIPHERAL-BLOOD STEM-CELLS FOR ALLOGRAFTING [J].
GOLDMAN, J .
BLOOD, 1995, 85 (06) :1413-1415
[9]   The place of blood stem cells in allogeneic transplantation [J].
Russell, N ;
Gratwohl, A ;
Schmitz, N .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (04) :747-753